May 2, 2016 – Stand Up To Cancer (SU2C) has awarded a total of $1 million to five teams of cancer researchers to advance “innovation in collaboration” among SU2C-‐affiliated scientists… Read on
Stand Up To Cancer Supports “Innovation in Collaboration” in Cancer Research with $1 Million for Five Teams through Phillip A… Read on
April 11, 2016 – Many members of the ovarian cancer community have been concerned about the results of GOG 252 clinical trial, which were released last month at the Society of Gynecologic Oncology’s Annual Meeting on Women’s Cancer… Read on
The Institute of Medicine (IOM) recently released a report commissioned by Congress, Ovarian Cancers: Evolving Paradigms in Research and Care. The report provides an in-depth look at the state of ovarian cancer in the United States… Read on
The Ovarian Cancer Research Alliance provides information based on medical research and best practices. Research regarding a connection between the use of talcum powder and increased ovarian cancer risk is inconclusive… Read on
As of January 2016, we are pleased to announce we are joining together to form Ovarian Cancer Research Alliance (OCRFA), the largest global organization dedicated to advancing ovarian cancer research while supporting women and their… Read on
Merger to create largest global ovarian cancer policy advocacy and research organization January 26, 2016 — Today, two of the nation’s foremost ovarian cancer policy advocacy and research organizations, the Ovarian Cancer National Alliance and… Read on
Sisters Jamie and Dawn Twedt launch a multifaceted campaign to make a difference… Read on
(12/14/15) | In 2015, OCRF grantees made several significant advances in the fight against ovarian cancer, including: Pinpointing two genes that trigger ovarian cancer Identifying a new therapeutic strategy for clear cell ovarian cancer Discovering… Read on
WASHINGTON — Today, the UK Collaborative Trial of Ovarian Cancer Screening (UKCTOCS) of the University College London released the results of its study to determine if the risk of ovarian cancer algorithm (ROCA), when used yearly in conjunction… Read on
